In agreement with our recent study (Al Murri et al, 2007), when potentially curative locoregional and systemic treatment based on hormonal receptor status were included in the multivariate survival analysis, none of the potentially prognostic clinicopathological and tumour-based inflammatory factors were independently significant. Here, NR4A1 is linked to neoplasm.